EX-4.3 3 v01587_ex4-3.txt EXHIBIT 4.3 The following schedule identifies the material details of the respective option agreements issued by the Registrant substantially identical to the form of Notice of Option Grant incorporated by reference into the accompany registration statement as Exhibit 4.2. Although not issued pursuant to the Registrant's 1995 Stock Option Plan, each Notice of Option Grant incorporates all of the terms of such plan. A copy of the 1995 Stock Option Plan is incorporated by reference into the accompanying registration statement as Exhibit 4.1. Option Holder Issuance Date No. of Shares Exercise Price ($) Termination Date ------------- ------------- ------------- ------------------ ----------- Leonard Firestone. 2/24/2003 584,060 (1) 0.40 2/24/2013 A. Joseph Rudick.. 4/12/2000 5,000 (2) 20.94 4/12/2010 2/20/2001 5,000 (2) 4.38 2/20/2011 2/19/2002 25,000 (2) 1.25 2/19/2012 2/19/2002 25,000 (3) 1.25 2/19/2012 2/19/2002 25,000 (4) 1.25 2/19/2012 3/28/2002 25,000 (5) 1.00 3/28/2012 Frederic P. Zotos. 2/19/2002 25,000 (6) 1.25 2/19/2012 2/19/2002 50,000 (4) 1.25 2/19/2012 3/28/2002 50,000 (5) 1.00 3/28/2012 Nicholas J. Rossettos......... 2/19/2002 10,000 (2) 1.25 2/19/2012 2/19/2002 10,000 (3) 1.25 2/19/2012 2/19/2002 10,000 (4) 1.25 2/19/2012 3/28/2002 25,000 (5) 1.00 3/28/2012 2/24/2003 292,030 (1) 0.40 2/24/2013 Michael L. Ferrari 2/19/2002 3,000 (6) 1.25 2/19/2012 2/19/2002 6,000 (4) 1.25 2/19/2012 3/28/2002 10,000 (5) 1.00 3/28/2012 Sarah E. Laut..... 2/19/2002 2,000 (6) 1.25 2/19/2012 2/19/2002 4,000 (4) 1.25 2/19/2012 3/28/2002 5,000 (5) 1.00 3/28/2012 ----------------- (1) Option vests 50% on first anniversary of grant date and then 50% on second anniversary. (2) Option vested 25% on issuance and then 25% on each anniversary thereafter. (3) Option vests upon the earlier of FDA approval of Avantix or 5 years from grant date; provided that to the extent optionee ceases to provide services to the Registrant before such vesting date, the option does not vest. (4) Option vested entirely in June 2002 upon the Registrant's license of its former rights to CT-3 to Indevus Pharmaceuticals, Inc. and remains exercisable for entire term of the option regardless of any change in optionee's employment status with the Registant. (5) Option vested upon issuance and remains exercisable for entire term of the option without regard to any change in optionee's employment status with the Registrant. (6) Represents one-half of original grant, which one-half was vested at February 21, 2003, the time of optionee's employment termination; remainder of option grant lapsed.